Covered recipient · General Payments record
SUSAN H CATCHINGS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,932.12
- Reported across 198 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $748.60 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $321.80 | 13 |
| Lilly USA, LLC | $99.15 | 5 |
| ABBVIE INC. | $93.04 | 5 |
| Acerta Pharma LLC | $61.24 | 3 |
| Abbott Laboratories | $39.90 | 2 |
| PFIZER INC. | $32.60 | 2 |
| Amgen Inc. | $22.49 | 1 |
| DEXCOM, INC. | $17.78 | 1 |
| VIVUS LLC | $16.72 | 1 |
| Teva Pharmaceuticals USA, Inc. | $15.95 | 1 |
| Merck Sharp & Dohme Corporation | $14.57 | 1 |
| Tris Pharma Inc | $13.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.53 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125186981 | CMS |
| Abbott Laboratories | $15.37 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125186984 | CMS |
| ABBVIE INC. | $14.94 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429142 | CMS |
| ABBVIE INC. | $15.26 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429144 | CMS |
| ABBVIE INC. | $22.65 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429146 | CMS |
| ABBVIE INC. | $18.15 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429148 | CMS |
| ABBVIE INC. | $22.04 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103429150 | CMS |
| Amgen Inc. | $22.49 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117220228 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.32 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123309678 | CMS |
| AstraZeneca Pharmaceuticals LP | $28.42 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123310330 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.50 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123311240 | CMS |
| Dexcom, Inc. | $17.78 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154659863 | CMS |
| Lilly USA, LLC | $19.55 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135869146 | CMS |
| Lilly USA, LLC | $21.29 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135967220 | CMS |
| Lilly USA, LLC | $21.56 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135960745 | CMS |
| Lilly USA, LLC | $15.75 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135957259 | CMS |
| Lilly USA, LLC | $21.00 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135948868 | CMS |
| Merck Sharp & Dohme LLC | $14.57 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141962300 | CMS |
| Novo Nordisk Inc | $7.02 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108565305 | CMS |
| Novo Nordisk Inc | $15.46 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108570640 | CMS |
| Novo Nordisk Inc | $19.82 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108564983 | CMS |
| Novo Nordisk Inc | $6.58 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108566601 | CMS |
| Novo Nordisk Inc | $1.03 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108570116 | CMS |
| Novo Nordisk Inc | $23.79 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108568175 | CMS |
| Novo Nordisk Inc | $22.17 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108570118 | CMS |
| Novo Nordisk Inc | $19.51 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108564481 | CMS |
| Novo Nordisk Inc | $20.12 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108564271 | CMS |
| Novo Nordisk Inc | $19.05 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108566999 | CMS |
| Novo Nordisk Inc | $24.36 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108569548 | CMS |
| Novo Nordisk Inc | $121.84 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108564015 | CMS |
| Novo Nordisk Inc | $21.05 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108565123 | CMS |
| PFIZER INC. | $15.15 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131848284 | CMS |
| PFIZER INC. | $17.45 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131110679 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.95 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151469912 | CMS |
| Tris Pharma Inc | $13.36 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147244067 | CMS |
| VIVUS LLC | $16.72 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129419321 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.